Human immunoglobulin (Lanzhou Lansheng)
人免疫球蛋白（兰州兰生）
Report date: 2022/03/01 16:02:27
Base Information
Drug NameHuman immunoglobulin (Lanzhou Lansheng)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2002/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLanzhou Lansheng Blood Products Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesLanzhou Lansheng Blood Products Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A